We identified three strategies through which tumors can escape immune surveillance via LFA-1-mediated processes: (I) alterations in LFA-1-mediated leukocyte infiltration into the tumor, (II) disruptions in LFA-1 functionality within the tumor, and (III) LFA-1-driven tumor invasiveness. The gene discussed is ITGB2; the disease is neoplasm.